Genomictree Inc. (KOSDAQ:228760)
South Korea · Delayed Price · Currency is KRW 11,180
-110 (-0.97%)
Sep 1, 2026, 3:30 PM KST
Genomictree Market Cap
Genomictree has a market cap or net worth of 276.9 billion as of September 1, 2026. Its market cap has decreased by -40.72% in one year.
Market Cap
276.90B
Enterprise Value
198.06B
Revenue
2.95B
Ranking
n/a
PE Ratio
n/a
Stock Price
11,180.00
ChartMarket Cap Chart
Since April 5, 2017, Genomictree's market cap has increased from 59.00B to 276.90B, an increase of 369.34%. That is a compound annual growth rate of 17.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 276.90B | -58.01% |
| Dec 30, 2025 | 659.41B | 34.41% |
| Dec 30, 2024 | 490.60B | 0.78% |
| Dec 28, 2023 | 486.82B | 168.25% |
| Dec 29, 2022 | 181.48B | -32.87% |
| Dec 30, 2021 | 270.36B | -7.66% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GI Innovation | 521.93B |
| AbClon | 519.75B |
| Medy-Tox | 463.40B |
| GC Corp. | 460.37B |
| Proteina | 396.16B |
| SillaJen | 360.24B |
| MEDIPOST | 350.99B |
| NeoImmuneTech | 248.16B |